Synthesis and biological evaluation of cis-restrained carbocyclic combretastatin A-4 analogs: Influence of the ring size and saturation on cytotoxic properties

被引:21
作者
Nowikow, Christina [1 ]
Fuerst, Rita [1 ,2 ]
Kauderer, Maria [1 ]
Dank, Christian [1 ]
Schmid, Walther [1 ]
Hajduch, Marian [3 ]
Rehulka, Jiri [3 ]
Gurska, Sona [3 ]
Mokshyna, Olena [3 ]
Polishchuk, Pavel [3 ]
Zupko, Istvan [4 ]
Dzubak, Petr [3 ]
Rinner, Uwe [1 ,5 ]
机构
[1] Univ Vienna, Inst Organ Chem, Wahringer Str 38, A-1090 Vienna, Austria
[2] Graz Univ Technol, Inst Organ Chem, Stremayrgasse 9, A-8010 Graz, Austria
[3] Palacky Univ Olomouc, Inst Mol & Translat Med, Fac Med & Dent, Hnevotinska 5, Olomouc, Czech Republic
[4] Univ Szeged, Dept Pharmacodynam & Biopharm, Eotvo U 6, H-6720 Szeged, Hungary
[5] Univ Appl Sci Krems, Dept Life Sci, Piaristengasse 1, A-3500 Krems, Austria
关键词
VASCULAR DISRUPTING AGENTS; ANTINEOPLASTIC AGENTS; CELL-GROWTH; TUBULIN; DERIVATIVES; BINDING; INHIBITORS; POTENT; STILBENE; PRODRUGS;
D O I
10.1016/j.bmc.2019.07.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Combretastatin A-4 (CA-4) is a highly cytotoxic natural product and several derivatives have been prepared which underwent clinical trial. These investigations revealed that the cis-stilbene moiety of the natural product is prone to undergo cis/trans isomerization under physiological conditions, reducing the overall activity of the drug candidates. Herein, we report the preparation of cis-restrained carbocyclic analogs of CA-4. The compounds, which differ by the size and hybridization of the carbocyclic ring have been evaluated for their cytotoxic properties and their ability to inhibit tubulin polymerization. Biological data, supported by molecular docking studies, identified cyclobutenyl and cyclobutyl derivatives of the natural product as highly promising drug candidates.
引用
收藏
页数:13
相关论文
共 58 条
[51]   ANTINEOPLASTIC AGENTS .166. ISOLATION, STRUCTURE, AND SYNTHESIS OF COMBRETASTATIN C-1 [J].
SINGH, SB ;
PETTIT, GR .
JOURNAL OF ORGANIC CHEMISTRY, 1989, 54 (17) :4105-4114
[52]   Review of Cytotoxic CA4 Analogues that Do Not Target Microtubules: Implications for CA4 Development [J].
Tarade, Daniel ;
Pandey, Siyaram ;
McNulty, James .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (16) :1507-1514
[53]   Regioselective Suzuki Coupling of Dihaloheteroaromatic Compounds as a Rapid Strategy To Synthesize Potent Rigid Combretastatin Analogues [J].
Theeramunkong, Sewan ;
Caldarelli, Antonio ;
Massarotti, Alberto ;
Aprile, Silvio ;
Caprioglio, Diego ;
Zaninetti, Roberta ;
Teruggi, Alessia ;
Pirali, Tracey ;
Grosa, Giorgio ;
Tron, Gian Cesare ;
Genazzani, Armando A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (14) :4977-4986
[54]   Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading [J].
Trott, Oleg ;
Olson, Arthur J. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2010, 31 (02) :455-461
[55]   Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4 [J].
Ty, Nancy ;
Pontikis, Renee ;
Chabot, Guy G. ;
Devillers, Emmanuelle ;
Quentin, Lionel ;
Bourg, Stephane ;
Florent, Jean-Claude .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (05) :1357-1366
[56]   Mitotic catastrophe: a mechanism for avoiding genomic instability [J].
Vitale, Ilio ;
Galluzzi, Lorenzo ;
Castedo, Maria ;
Kroemer, Guido .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (06) :384-391
[57]   THE INTERACTION WITH TUBULIN OF A SERIES OF STILBENES BASED ON COMBRETASTATIN A-4 [J].
WOODS, JA ;
HADFIELD, JA ;
PETTIT, GR ;
FOX, BW ;
MCGOWN, AT .
BRITISH JOURNAL OF CANCER, 1995, 71 (04) :705-711
[58]   Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site [J].
Wu, Xiaoxin ;
Wang, Qinghui ;
Li, Wei .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (10) :1325-1338